Skip to main content


The National Institutes of Health (NIH) campuses host a variety of events that inform, challenge, and unite the biomedical research community. IRP investigators lead or participate in many of these events, and they regularly present their work at scientific conferences at the NIH and around the world. We invite you to learn about (and possibly join us in) some of our upcoming events. Unless otherwise noted, times listed are Eastern Standard Time (EST).

Friday, July 29, 2016, 9:00 am to 3:00 pm

Natcher Conference Center (Bldg 45)

Summer Poster Day is your time to share the research you have been conducting at the NIH and at the same time develop your communication and networking skills. Any student (high school, college, medical/dental, or graduate) working in an intramural research group this summer may present. You may not have final results. However, you can still present background information on your project, any data you may have collected, or a discussion of the technical problems you encountered.

We encourage all current summer interns in Bethesda/Rockville, Baltimore, and Frederick to present at this event. During the session, you will spend a period of time at your poster discussing your project informally with your peers and other members of the NIH community.

Friday, August 5, 2016, 11:30 am to 1:00 pm (luncheon reception to follow)

Lipsett Amphitheater, NIH Clinical Center (Bldg 10)


The 2006 AAAS Wachtel Cancer Research Award and Lecture is “Molecular dissection of disease progression in adult diffuse glioma” by Roel Verhaak, Ph.D., Associate Professor, MD Anderson Cancer Center. This lecture is the fourth lecture for the "AAAS Martin and Rose Wachtel Cancer Research Award" sponsored by The American Association for the Advancement of Science and Science Translational Medicine. The Center for Cancer Research, National Cancer Institute is co-hosting the event. The Wachtel Cancer Research Award is presented to young cancer researcher(s) who has made outstanding contributions to the cancer field. Verhaak is best known for his research on genomics and transcriptomics of adult diffuse glioma. The Verhaak lab was the first to report commonly occurring fusion transcripts in glioblastoma and to perform unbiased genomic comparisons of primary and recurrent disease, and it has established a genome-wide DNA methylation-based classification intended to complement pathohistological review for optimal clinical classification of brain tumors. This approach is increasingly being adopted by clinical centers worldwide. Most recently, the lab is using various sequencing methodologies to gain insights into the pathobiology of cancer with the ultimate goal of improving patient outcomes. RSVP by August 1st at

Thursday, September 8, 2016 to Friday, September 9, 2016

Room 620/630, Bldg 35, NIH Bethesda Campus

Join us for the 4th NCI-Pancreatic Cancer Symposium. This year’s theme is “Current Advances and Future Challenges in Research and Treatment.” Pancreatic cancer remains one of the most lethal malignancies, and is expected to be the second leading cause of death due to cancer by 2020 in the United States. Recent progress in the basic and translational research has identified molecular subgroups, critical pathways associated with disease aggressiveness and novel molecular targets that could be harnessed in improving survival in patients with pancreatic cancer. This symposium presents recent advances in our understanding of the development, progression, early detection and treatment of pancreatic cancer, and would provide an exciting forum to discuss the current advances and challenges in improving diagnosis, prevention and treatment of this lethal malignancy. Registration is free but seating is limited, so please register at

Thursday, September 22, 2016 to Friday, September 23, 2016

Bethesda North Marriott and Conference Center, 5701 Marinelli Road, North Bethesda, Maryland

Zika Virus (ZIKV) is a growing, global epidemic. ZIKV has been associated with numerous birth and developmental defects, such as microcephaly, and other pregnancy and birth-related problems, including miscarriages, stillbirths, and other in utero complications. Because of these health issues, it is imperative that the scientific community understand the effects of ZIKV on pregnancy and pregnancy outcomes. The purpose of this workshop is to identify optimal approaches for treating and caring for the generation of children exposed to ZIKV in the womb.

This workshop is co-sponsored by the NICHD and the Office of Research on Women’s Health (ORWH). The objectives are to:

  • Develop a clinical and research strategy on how to appropriately  assess, evaluate, and monitor the neonate/infant/child affected by ZIKV in utero
  • Describe the available complications of in utero ZIKV exposure and infection
  • Use available information from other vertically transmitted pathogens to provide recommendations for assessment, evaluation, and management
  • Outline the research needs for treatment and rehabilitation approaches that optimize cognitive and physical function for Zika-affected children; and
  • Evaluate and expand on treatment options currently offered, such as intensive physical therapy and immersion therapies, role of parents and caregivers in treatments, including the evidence base for these therapies and current research gaps.

To register, visit If you require a sign language interpreters and/or reasonable accommodations to participate, please contact Christine Rogers (301-402-2205 or or the Federal TTY Relay Number (1-800-877-8339). Please make your requests at least 5 days in advance of the event.

For logistical questions, contact: Carly Sullivan at Palladian Partners, Inc. (Tel: 301-273-2817; Email: For content or meeting questions, contact: Bill Kapogiannis, Maternal and Pediatric Infectious Disease Branch, Division of Extramural Research, NICHD (Email:

Tuesday, October 18, 2016, 9:00 am to 4:30 pm

Auditorium (Room 620/630), Bldg 35 

The call-for-abstracts deadline for The Symposium on Cancer Health Disparities is September 30. See for more information.

About the symposium: Not all segments of the U.S. population have equally benefited from the advances in our knowledge and treatment of cancer. As a result, minority, immigrant, and financially disadvantaged populations continue to experience an excessive cancer burden due to barriers in access to health care, cultural barriers, and exposure to carcinogens and pathogens. The causes of these disparities are clearly multifaceted, and may include tumor biological and genetic factors, and their interaction with the environment. This symposium will present recent advances in our understanding of the causes of cancer health disparities, including financial toxicity, lifestyle factors, microbiome, and ancestry, by highlighting various cancer sites, and will discuss disparities in cancer outcome and survivorship, and strategies to reduce these disparities.